Nevada
|
000-27237
|
65-0622463
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
6860 Broadway, Denver, CO
|
80221
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing
obligation of the registrant under any of the following
provisions.
|
|
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit
Number
|
Description
|
|
GeneThera,
Inc.,
a Nevada
Corporation
|
|
|
|
|
|
|
|
By:
|
/s/ Antonio
Milici
|
|
|
|
Antonio Milici,
CEO
|
|